NCT00555789 - 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients | Biotech Hunter

Enrollment

137

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Kidney Transplantation

Interventions

DRUG

AEB071

200mg oral b.i.d.

DRUG

mycophenolic plus tacrolimus

720mg b.i.d. 2yrs

Trial Locations (27)

3010

Novartis Investigative Site, Bern

4031

Novartis Investigative Site, Basel

8091

Novartis Investigative Site, Zurich

13353

Novartis Investigative Site, Berlin

28041

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

30625

Novartis Investigative Site, Hanover

31403

Novartis Investigative Site, Toulouse

35128

Novartis Investigative Site, Padua

40138

Novartis Investigative Site, Bologna

44035

Novartis Investigative Site, Nantes

45122

Novartis Investigative Site, Essen

46017

Novartis Investigative Site, Valencia

50134

Novartis Investigative Site, Florence

53706

Novartis Investigative Site, Madison

69120

Novartis Investigative Site, Heidelberg

75015

Novartis Investigative Site, Paris

94270

Novartis Investigative Site, Le Kremlin-Bicêtre

94143-0780

Novartis Investigative Site, San Francisco

B3H 1V7

Novartis Investigative Site, Halifax

Unknown

Novartis Investigative Site, Berlin

Novartis Investigative Site, Cologne

Novartis Investigative Site, London

Novartis Investigative Site, Manchester

08907

Novartis Investigative Site, Llobregat

CF14 4XW

Novartis Investigative Site, Cardiff

G11 6NT

Novartis Investigative Site, Glasgow